Phenoxybenzamine and dibenamine interactions with calcium channel effectors of the muscarinic receptor.
D000818:Animals; D001667:Binding, Competitive; D002118:Calcium / Q000378:metabolism*; D002217:Carbachol / Q000494:pharmacology; D002478:Cells, Cultured; D006152:Cyclic GMP / Q000378:metabolism; D003983:Dibenzylchlorethamine / Q000494:pharmacology*; D007473:Ion Channels / Q000187:drug effects* / Q000378:metabolism; D051379:Mice; D009374:Neoplasms, Experimental / Q000378:metabolism; D009447:Neuroblastoma / Q000378:metabolism; D010643:Phenoxybenzamine / Q000494:pharmacology*; D011813:Quinuclidinyl Benzilate / Q000378:metabolism; D011950:Receptors, Cholinergic / Q000187:drug effects*; D011976:Receptors, Muscarinic / Q000187:drug effects*
D007473:Ion Channels; D011950:Receptors, Cholinergic; D011976:Receptors, Muscarinic; D010643:Phenoxybenzamine; D003983:Dibenzylchlorethamine; D011813:Quinuclidinyl Benzilate; D002217:Carbachol; D006152:Cyclic GMP; D002118:Calcium